Black race are at no higher risk of death from prostate cancer (PCa) than white men if they receive the same treatment for similar disease stages in an equal-access setting, according to a new study. The finding suggests that socioeconomic factors, rather than biological differences; may explain why PCa-related mortality (PCSM) is higher among black…
In the prospective, open-label study of MRI-guided transurethral ultrasound whole-gland ablation (TULSA-PRO); 96% of men had a Prostate-specific antigen decrease of at least 75% at 1 year. However, approximately 80% of the men who entered the study with Gleason grade group 2 (Gleason score 7); prostate cancer no longer had evidence of Gleason grade group…
Researchers analyzed data on 143,279 postmenopausal women from the Women’s Health Initiative study; and found former smokers who quit within the last 10 years were 25% less likely to be diagnose; with bladder cancer compared to current smokers. Women’s bladder cancer risk continued to fall with greater years since quitting but remained higher than the…
Urinary tract infections are the most common type of health care-related infection; according to the National Healthcare Safety Network. While the infection is usually harmless for the young; it can have deadly consequences for the elderly. Researchers at Oregon State University explored more than 3,000 at-risk patients. The study reveal that the risk of infection…
The use of 5-alpha-reductase inhibitors (5-ARIs) for voiding symptoms from enlarged prostate; and PSA screening for early detection of prostate cancer are among the most frequent urologic interventions in men. When using 5-ARIs (finasteride, dutasteride); the observe PSA level should be adjust (by a factor of 2) to obtain the representative PSA level. While 5-ARIs…
Hypofractionated proton therapy appeared effective and associated with low rates; of toxicity among men with prostate cancer; in International Journal of Radiation Oncology Biology Physics. However, these results suggest that this shorter, higher-dose delivery method may have comparable outcomes to those of standard fractionated proton therapy. “However, study provides some prospective evidence that the higher…
Prostate cancer (PCa) is the most common form of cancer in males and the second leading cause of death after lung cancer in the United States. According to the American Cancer Society, it is also the first leading cause of cancer mortality in males aged 65; and older in the United States. But there are…
Researchers has revealed that a new urine test can detect aggressive prostate cancer cases that need treatment up to 5 years sooner than other diagnostic methods. They revealed that an experimental urine test; called Prostate Urine Risk (PUR), can distinguish who will and who will not require treatment within the first 5 years of diagnosis.…
Alzheimer’s disease may be a risk for older prostate cancer patients given hormone-blocking treatment, a large, U.S. government-funded analysis found. Previous evidence has been mix on whether the treatment might be linked with mental decline. But experts say the new results stand out because they’re from a respected national cancer database; and the men were…
“Practicing doctors therefore need to ensure they discuss the benefits and harms of prostate cancer screening; with men considering screening, attending to their values and preferences before as they consider the possible benefits, and the harms and burdens, of screening,” Dr. Kari Tikkinen of Helsinki University Hospital, in Finland, who worked on the study, told…
An autoimmune disease that appears to affect men with testicular cancer is discovered; using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and University of California, San Francisco (UCSF). Called “testicular cancer-associated paraneoplastic encephalitis,” the disease causes severe neurological symptoms in men. But they progressively lose control of their limbs, eye movements, and,…
Prostate cancer represents a major health challenge and there is currently no effective treatment once it has advanced to the aggressive; metastatic stage. A new has reveal a key cellular mechanism that contributes to aggressive prostate cancer; and supporting a new clinical trial. The study was publish in the journal Clinical Cancer Research. However, the…